# Real-World Clinical Study for Malignant Tumor-Induced Cachexia

> **NCT07008248** · — · WITHDRAWN · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.**

## Conditions studied

- Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia
- Multicenter Observational Study

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07008248
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-15
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company strategy adjustment
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07008248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07008248, "Real-World Clinical Study for Malignant Tumor-Induced Cachexia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07008248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*